A new target for antibiotic design

C - Chemistry – Metallurgy – 12 – Q

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12Q 1/48 (2006.01) C12Q 1/18 (2006.01) C12Q 1/68 (2006.01)

Patent

CA 2255460

The present invention relates to a method to design antibiotics, which comprises testing of compounds which inhibit bacterial cell division by blocking the s-adenosylmethionine-dependent step of formation of crosswall during cell division in bacteria and other microorganism. The S-adenosylmethionine-dependent step is catalyzed by the product of the yabC gene (accession number COO2042, orf B) of Escherichia coli. This gene has been cloned, together with the first gene of the same operon, yabB (accession number COO2041, orfC). Overproduction and underproduction of the yabC gene product is toxic to E. coli. Compounds which induce or repress the promoter of the yabBC, or increase production of the yabC gene product, as well as inhibitors of the yabC S-adenosylmethionine-dependent methylase will act as antibiotics.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

A new target for antibiotic design does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with A new target for antibiotic design, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and A new target for antibiotic design will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1732337

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.